Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

BMP4 gene is crucial for hair follicle development in Liaoning cashmere goats.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

BBS7 is crucial for maintaining healthy periodontal ligaments by supporting Shh signaling.

This is the first known case of parathyroid cancer in a patient with Birt Hogg Dube Syndrome.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Bicalutamide improves hair density in women safely.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Somatic BHD mutations are rare in Japanese renal tumors.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.